Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| 1 |
iShares Russell 2000 ETF
IWM
|
+$858M |
| 2 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$284M |
| 3 |
Fortive
FTV
|
+$233M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$196M |
| 5 |
JD.com
JD
|
+$185M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.02B |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$416M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$366M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$309M |
Sector Composition
| 1 | Technology | 10.79% |
| 2 | Financials | 10.35% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Healthcare | 7.64% |
| 5 | Industrials | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Vanguard Mid-Cap Value ETF
VOE
$18.9B
| $4.39M | ﹤0.01% |
38,816
+742
| +2% | +$83.9K |
|
1052
Alnylam Pharmaceuticals
ALNY
$59.5B
| $4.39M | ﹤0.01% |
50,134
+11,947
| +31% | +$1.05M |
|
1053
iShares Core Dividend Growth ETF
DGRO
$34.2B
| $4.39M | ﹤0.01% |
118,410
-12,388
| -9% | -$459K |
|
1054
Huntington Ingalls Industries
HII
$10.8B
| $4.37M | ﹤0.01% |
17,074
-13,671
| -44% | -$3.5M |
|
|
DCUD
1055
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $4.37M | ﹤0.01% |
92,437
+80,649
| +684% | +$3.81M |
|
1056
Twilio
TWLO
$16.3B
| $4.36M | ﹤0.01% |
50,486
-553,641
| -92% | -$47.8M |
|
1057
NVR
NVR
$22.4B
| $4.35M | ﹤0.01% |
1,762
-4,384
| -71% | -$10.8M |
|
1058
Fair Isaac
FICO
$35.5B
| $4.35M | ﹤0.01% |
19,025
-3,589
| -16% | -$820K |
|
|
ONCE
1059
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $4.34M | ﹤0.01% |
79,601
+34,038
| +75% | +$1.86M |
|
1060
Arrowhead Research
ARWR
$4.24B
| $4.34M | ﹤0.01% |
226,228
+97,328
| +76% | +$1.87M |
|
1061
Radian Group
RDN
$5.04B
| $4.33M | ﹤0.01% |
209,621
-461,762
| -69% | -$9.54M |
|
|
DHC
1062
Diversified Healthcare Trust
DHC
$1.11B
| $4.33M | ﹤0.01% |
246,388
-42,747
| -15% | -$751K |
|
1063
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$57.9B
| $4.33M | ﹤0.01% |
51,794
+5,994
| +13% | +$501K |
|
1064
iShares 1-3 Year Treasury Bond ETF
SHY
$24.3B
| $4.32M | ﹤0.01% |
52,021
-27,312
| -34% | -$2.27M |
|
1065
Charles River Laboratories
CRL
$7.65B
| $4.29M | ﹤0.01% |
31,903
-308
| -1% | -$41.4K |
|
|
LSI
1066
DELISTED
Life Storage, Inc.
LSI
| $4.29M | ﹤0.01% |
67,665
+130
| +0.2% | +$8.25K |
|
1067
Chemed
CHE
$6.59B
| $4.29M | ﹤0.01% |
13,424
+1,247
| +10% | +$399K |
|
|
BEAT
1068
DELISTED
BioTelemetry, Inc.
BEAT
| $4.27M | ﹤0.01% |
66,272
+50,189
| +312% | +$3.24M |
|
1069
Red Robin
RRGB
$117M
| $4.27M | ﹤0.01% |
106,284
+47,679
| +81% | +$1.91M |
|
1070
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.95B
| $4.26M | ﹤0.01% |
253,350
+4,230
| +2% | +$71.2K |
|
|
CVRR
1071
DELISTED
CVR Refining, LP
CVRR
| $4.22M | ﹤0.01% |
214,276
-1,125,686
| -84% | -$22.2M |
|
|
PPEM
1072
DELISTED
PortfolioPlus Emerging Markets ETF
PPEM
| $4.22M | ﹤0.01% |
200,000
| – | – |
|
|
BBU
1073
Brookfield Business Partners
BBU
$2.46B
| $4.22M | ﹤0.01% |
143,373
-49
| -0% | -$1.44K |
|
1074
West Pharmaceutical
WST
$18.3B
| $4.21M | ﹤0.01% |
34,130
+22,617
| +196% | +$2.79M |
|
1075
AnaptysBio
ANAB
$583M
| $4.21M | ﹤0.01% |
42,182
-8,941
| -17% | -$892K |
|